284 related articles for article (PubMed ID: 2468996)
1. Nuclear proteins that bind the human gamma-globin gene promoter: alterations in binding produced by point mutations associated with hereditary persistence of fetal hemoglobin.
Gumucio DL; Rood KL; Gray TA; Riordan MF; Sartor CI; Collins FS
Mol Cell Biol; 1988 Dec; 8(12):5310-22. PubMed ID: 2468996
[TBL] [Abstract][Full Text] [Related]
2. The effects of HPFH mutations in the human gamma-globin promoter on binding of ubiquitous and erythroid specific nuclear factors.
Mantovani R; Malgaretti N; Nicolis S; Ronchi A; Giglioni B; Ottolenghi S
Nucleic Acids Res; 1988 Aug; 16(16):7783-97. PubMed ID: 2458563
[TBL] [Abstract][Full Text] [Related]
3. DNA sequences regulating human globin gene transcription in nondeletional hereditary persistence of fetal hemoglobin.
Ottolenghi S; Mantovani R; Nicolis S; Ronchi A; Giglioni B
Hemoglobin; 1989; 13(6):523-41. PubMed ID: 2481658
[TBL] [Abstract][Full Text] [Related]
4. Sites I and II upstream of the A gamma globin gene bind nuclear factors and affect gene expression.
Lloyd JA; Lee RF; Menon AG; Lingrel JB
Prog Clin Biol Res; 1989; 316A():139-48. PubMed ID: 2480607
[TBL] [Abstract][Full Text] [Related]
5. Methylation-enhanced binding of Sp1 to the stage selector element of the human gamma-globin gene promoter may regulate development specificity of expression.
Jane SM; Gumucio DL; Ney PA; Cunningham JM; Nienhuis AW
Mol Cell Biol; 1993 Jun; 13(6):3272-81. PubMed ID: 7684493
[TBL] [Abstract][Full Text] [Related]
6. A fetal globin gene mutation in A gamma nondeletion hereditary persistence of fetal hemoglobin increases promoter strength in a nonerythroid cell.
Rixon MW; Gelinas RE
Mol Cell Biol; 1988 Feb; 8(2):713-21. PubMed ID: 2451123
[TBL] [Abstract][Full Text] [Related]
7. Increased gamma-globin expression in a nondeletion HPFH mediated by an erythroid-specific DNA-binding factor.
Martin DI; Tsai SF; Orkin SH
Nature; 1989 Mar; 338(6214):435-8. PubMed ID: 2467208
[TBL] [Abstract][Full Text] [Related]
8. The T----C substitution at -198 of the A gamma-globin gene associated with the British form of HPFH generates overlapping recognition sites for two DNA-binding proteins.
Fischer KD; Nowock J
Nucleic Acids Res; 1990 Oct; 18(19):5685-93. PubMed ID: 1699206
[TBL] [Abstract][Full Text] [Related]
9. The deletion of the distal CCAAT box region of the A gamma-globin gene in black HPFH abolishes the binding of the erythroid specific protein NFE3 and of the CCAAT displacement protein.
Mantovani R; Superti-Furga G; Gilman J; Ottolenghi S
Nucleic Acids Res; 1989 Aug; 17(16):6681-91. PubMed ID: 2476717
[TBL] [Abstract][Full Text] [Related]
10. Role of the duplicated CCAAT box region in gamma-globin gene regulation and hereditary persistence of fetal haemoglobin.
Ronchi A; Berry M; Raguz S; Imam A; Yannoutsos N; Ottolenghi S; Grosveld F; Dillon N
EMBO J; 1996 Jan; 15(1):143-9. PubMed ID: 8598197
[TBL] [Abstract][Full Text] [Related]
11. A role for the distal CCAAT box of the gamma-globin gene in Hb switching.
Katsube T; Fukumaki Y
J Biochem; 1995 Jan; 117(1):68-76. PubMed ID: 7539789
[TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of the human fetal-to-adult globin switching.
Katsube T; Fucharoen S; Tojo H; Fukumaki Y
Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():212-20. PubMed ID: 8629109
[TBL] [Abstract][Full Text] [Related]
13. Sequences located 3' to the breakpoint of the hereditary persistence of fetal hemoglobin-3 deletion exhibit enhancer activity and can modify the developmental expression of the human fetal A gamma-globin gene in transgenic mice.
Anagnou NP; Perez-Stable C; Gelinas R; Costantini F; Liapaki K; Constantopoulou M; Kosteas T; Moschonas NK; Stamatoyannopoulos G
J Biol Chem; 1995 Apr; 270(17):10256-63. PubMed ID: 7537267
[TBL] [Abstract][Full Text] [Related]
14. The -175T----C mutation increases promoter strength in erythroid cells: correlation with evolutionary conservation of binding sites for two trans-acting factors.
Gumucio DL; Lockwood WK; Weber JL; Saulino AM; Delgrosso K; Surrey S; Schwartz E; Goodman M; Collins FS
Blood; 1990 Feb; 75(3):756-61. PubMed ID: 1688723
[TBL] [Abstract][Full Text] [Related]
15. T to C substitution at -175 or -173 of the gamma-globin promoter affects GATA-1 and Oct-1 binding in vitro differently but can independently reproduce the hereditary persistence of fetal hemoglobin phenotype in transgenic mice.
Liu LR; Du ZW; Zhao HL; Liu XL; Huang XD; Shen J; Ju LM; Fang FD; Zhang JW
J Biol Chem; 2005 Mar; 280(9):7452-9. PubMed ID: 15613485
[TBL] [Abstract][Full Text] [Related]
16. G gamma A gamma (beta+) hereditary persistence of fetal hemoglobin: the G gamma -158 C-->T mutation in cis to the -175 T-->C mutation of the A gamma-globin gene results in increased G gamma-globin synthesis.
Coleman MB; Adams JG; Steinberg MH; Plonczynski MW; Harrell AH; Castro O; Winter WP
Am J Hematol; 1993 Feb; 42(2):186-90. PubMed ID: 7679879
[TBL] [Abstract][Full Text] [Related]
17. Purification and identification of proteins that bind to the hereditary persistence of fetal hemoglobin -198 mutation in the gamma-globin gene promoter.
Olave IA; Doneanu C; Fang X; Stamatoyannopoulos G; Li Q
J Biol Chem; 2007 Jan; 282(2):853-62. PubMed ID: 17114178
[TBL] [Abstract][Full Text] [Related]
18. Gamma-globin gene promoter elements required for interaction with globin enhancers.
Langdon SD; Kaufman RE
Blood; 1998 Jan; 91(1):309-18. PubMed ID: 9414299
[TBL] [Abstract][Full Text] [Related]
19. The -117 mutation in Greek HPFH affects the binding of three nuclear factors to the CCAAT region of the gamma-globin gene.
Superti-Furga G; Barberis A; Schaffner G; Busslinger M
EMBO J; 1988 Oct; 7(10):3099-107. PubMed ID: 3181130
[TBL] [Abstract][Full Text] [Related]
20. Natural regulatory mutations elevate the fetal globin gene via disruption of BCL11A or ZBTB7A binding.
Martyn GE; Wienert B; Yang L; Shah M; Norton LJ; Burdach J; Kurita R; Nakamura Y; Pearson RCM; Funnell APW; Quinlan KGR; Crossley M
Nat Genet; 2018 Apr; 50(4):498-503. PubMed ID: 29610478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
